Image courtesy Epilepsy.com THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST A new therapeutic approach, supported by CIRM, that blocks the signals in the brain that can cause epilepsy has been given permission by the US Food and Drug Administration (FDA) to be tested in a clinical trial. Nearly 3.5 million Americans suffer from … Continue reading Promising new approach for people with epilepsy
Dr. Cory Nicholas
CIRM Board Awards $15.8 Million to Four Translational Research Projects
Last week, the CIRM Board approved $32.92 million in awards directed towards four new clinical trials in vision related diseases and Parkinson's Disease. In addition to these awards, the Board also approved investing $15.80 million in four awards in the Translational Research program. The goal of this program is to help promising projects complete the … Continue reading CIRM Board Awards $15.8 Million to Four Translational Research Projects